Literature DB >> 23606141

Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer.

John V Hegde1, Robert V Mulkern, Lawrence P Panych, Fiona M Fennessy, Andriy Fedorov, Stephan E Maier, Clare M C Tempany.   

Abstract

Magnetic resonance (MR) examinations of men with prostate cancer are most commonly performed for detecting, characterizing, and staging the extent of disease to best determine diagnostic or treatment strategies, which range from biopsy guidance to active surveillance to radical prostatectomy. Given both the exam's importance to individual treatment plans and the time constraints present for its operation at most institutions, it is essential to perform the study effectively and efficiently. This article reviews the most commonly employed modern techniques for prostate cancer MR examinations, exploring the relevant signal characteristics from the different methods discussed and relating them to intrinsic prostate tissue properties. Also, a review of recent articles using these methods to enhance clinical interpretation and assess clinical performance is provided. J. Magn. Reson. Imaging 2013;37:1035-1054. © 2013 Wiley Periodicals, Inc.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23606141      PMCID: PMC3741996          DOI: 10.1002/jmri.23860

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  105 in total

1.  MR-perfusion (MRP) and diffusion-weighted imaging (DWI) in prostate cancer: quantitative and model-based gadobenate dimeglumine MRP parameters in detection of prostate cancer.

Authors:  M K Scherr; M Seitz; U G Müller-Lisse; M Ingrisch; M F Reiser; U L Müller-Lisse
Journal:  Eur J Radiol       Date:  2010-05-14       Impact factor: 3.528

2.  Comparison between population average and experimentally measured arterial input function in predicting biopsy results in prostate cancer.

Authors:  Ran Meng; Silvia D Chang; Edward C Jones; S Larry Goldenberg; Piotr Kozlowski
Journal:  Acad Radiol       Date:  2010-01-13       Impact factor: 3.173

3.  Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging.

Authors:  Kazuhiro Kitajima; Yasushi Kaji; Yoshitatsu Fukabori; Ken-ichiro Yoshida; Narufumi Suganuma; Kazuro Sugimura
Journal:  J Magn Reson Imaging       Date:  2010-03       Impact factor: 4.813

4.  N4ITK: improved N3 bias correction.

Authors:  Nicholas J Tustison; Brian B Avants; Philip A Cook; Yuanjie Zheng; Alexander Egan; Paul A Yushkevich; James C Gee
Journal:  IEEE Trans Med Imaging       Date:  2010-04-08       Impact factor: 10.048

5.  Apparent diffusion coefficient of line scan diffusion image in normal prostate and prostate cancer--comparison with single-shot echo planner image.

Authors:  Takeshi Yoshizako; Akihiko Wada; Koji Uchida; Shinji Hara; Mikio Igawa; Hajime Kitagaki; Stephan E Maier
Journal:  Magn Reson Imaging       Date:  2010-09-15       Impact factor: 2.546

6.  Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging.

Authors:  Aytekin Oto; Arda Kayhan; Yulei Jiang; Maria Tretiakova; Cheng Yang; Tatjana Antic; Farid Dahi; Arieh L Shalhav; Gregory Karczmar; Walter M Stadler
Journal:  Radiology       Date:  2010-09-15       Impact factor: 11.105

7.  Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation.

Authors:  Baris Turkbey; Peter A Pinto; Haresh Mani; Marcelino Bernardo; Yuxi Pang; Yolanda L McKinney; Kiranpreet Khurana; Gregory C Ravizzini; Paul S Albert; Maria J Merino; Peter L Choyke
Journal:  Radiology       Date:  2010-04       Impact factor: 11.105

8.  Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features.

Authors:  Deanna L Langer; Theodorus H van der Kwast; Andrew J Evans; Anna Plotkin; John Trachtenberg; Brian C Wilson; Masoom A Haider
Journal:  Radiology       Date:  2010-05       Impact factor: 11.105

9.  A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance.

Authors:  Nicholas J van As; Nandita M de Souza; Sophie F Riches; Veronica A Morgan; Sayid A Sohaib; David P Dearnaley; Chris C Parker
Journal:  Eur Urol       Date:  2008-12-06       Impact factor: 20.096

10.  Peripheral zone prostate cancer. Pre-treatment evaluation with MR and 3D ¹H MR spectroscopic imaging: correlation with pathologic findings.

Authors:  Sabina Giusti; Davide Caramella; Elena Fruzzetti; Michele Lazzereschi; Adele Tognetti; Carlo Bartolozzi
Journal:  Abdom Imaging       Date:  2009-09-12
View more
  89 in total

1.  Prostatic ductal adenocarcinoma: an aggressive tumour variant unrecognized on T2 weighted magnetic resonance imaging (MRI).

Authors:  Nicola Schieda; Niamh Coffey; Previn Gulavita; Omran Al-Dandan; Wael Shabana; Trevor A Flood
Journal:  Eur Radiol       Date:  2014-04-01       Impact factor: 5.315

2.  Open Source Platform for Transperineal In-Bore MRI-Guided Targeted Prostate Biopsy.

Authors:  Christian Herz; Kyle MacNeil; Peter A Behringer; Junichi Tokuda; Alireza Mehrtash; Parvin Mousavi; Ron Kikinis; Fiona M Fennessy; Clare M Tempany; Kemal Tuncali; Andriy Fedorov
Journal:  IEEE Trans Biomed Eng       Date:  2019-05-23       Impact factor: 4.538

3.  Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.

Authors:  Rakesh Shiradkar; Soumya Ghose; Ivan Jambor; Pekka Taimen; Otto Ettala; Andrei S Purysko; Anant Madabhushi
Journal:  J Magn Reson Imaging       Date:  2018-05-07       Impact factor: 4.813

4.  Evaluation of fitting models for prostate tissue characterization using extended-range b-factor diffusion-weighted imaging.

Authors:  Fredrik Langkilde; Thiele Kobus; Andriy Fedorov; Ruth Dunne; Clare Tempany; Robert V Mulkern; Stephan E Maier
Journal:  Magn Reson Med       Date:  2017-07-17       Impact factor: 4.668

Review 5.  Clinical and research applications of simultaneous positron emission tomography and MRI.

Authors:  F Fraioli; S Punwani
Journal:  Br J Radiol       Date:  2013-11-14       Impact factor: 3.039

6.  Classification of Clinical Significance of MRI Prostate Findings Using 3D Convolutional Neural Networks.

Authors:  Alireza Mehrtash; Alireza Sedghi; Mohsen Ghafoorian; Mehdi Taghipour; Clare M Tempany; William M Wells; Tina Kapur; Parvin Mousavi; Purang Abolmaesumi; Andriy Fedorov
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2017-03-03

7.  Accelerated Segmented Diffusion-Weighted Prostate Imaging for Higher Resolution, Higher Geometric Fidelity, and Multi-b Perfusion Estimation.

Authors:  Pelin Aksit Ciris; Jr-Yuan George Chiou; Daniel I Glazer; Tzu-Cheng Chao; Clare M Tempany-Afdhal; Bruno Madore; Stephan E Maier
Journal:  Invest Radiol       Date:  2019-04       Impact factor: 6.016

8.  Role of multiparametric magnetic resonance imaging in the diagnosis of prostate cancer.

Authors:  Soroush Rais-Bahrami; Baris Turkbey; Kinzya B Grant; Peter A Pinto; Peter L Choyke
Journal:  Curr Urol Rep       Date:  2014-03       Impact factor: 3.092

9.  The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancer.

Authors:  François Marliere; Philippe Puech; Ahmed Benkirane; Arnauld Villers; Laurent Lemaitre; Xavier Leroy; Nacim Betrouni; Adil Ouzzane
Journal:  World J Urol       Date:  2014-05-12       Impact factor: 4.226

Review 10.  Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI.

Authors:  Ryan L Brunsing; Natalie M Schenker-Ahmed; Nathan S White; J Kellogg Parsons; Christopher Kane; Joshua Kuperman; Hauke Bartsch; Andrew Karim Kader; Rebecca Rakow-Penner; Tyler M Seibert; Daniel Margolis; Steven S Raman; Carrie R McDonald; Nikdokht Farid; Santosh Kesari; Donna Hansel; Ahmed Shabaik; Anders M Dale; David S Karow
Journal:  J Magn Reson Imaging       Date:  2016-08-16       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.